All In Biotech

Free tool

FAERS Monitor: Isolyte P In Dextrose 5% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019873 or its brand name (Isolyte P In Dextrose 5% In Plastic Container, Dextrose, Magnesium Chloride, Potassium Chloride, Potassium Phosphate, Dibasic, Sodium Acetate). Reports on generic versions are filed under their own applications.

Reports

7

Serious

7

100% of reports

Hospitalization

4

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • alanine aminotransferase increased2
  • aspartate aminotransferase increased2
  • blood bilirubin increased2
  • drug abuse2
  • gamma-glutamyltransferase increased2
  • neuroleptic malignant syndrome2
  • off label use2
  • anaemia1
  • asthenia1
  • autoimmune hepatitis1
  • cardiac failure1
  • death1
  • drug ineffective1
  • escherichia urinary tract infection1
  • hyperthermia malignant1

Reports by year received

View as table
YearReports
20141
20162
20201
20263

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,152 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperthermia malignant12021.3329.0504
escherichia urinary tract infection1707.0115.1176
neuroleptic malignant syndrome2506.8157.1567
autoimmune hepatitis1432.170.4107
gamma-glutamyltransferase increased2271.284.1302
blood bilirubin increased2222.569.0248
aspartate aminotransferase increased2113.135.1125
alanine aminotransferase increased297.930.3107
drug abuse272.222.479
cardiac failure137.46.18
anaemia115.82.63
asthenia18.01.31
off label use26.92.15
death13.50.60
drug ineffective12.30.40

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.